Portage Biotech receives Nasdaq non-compliance letter
PRTG Stock | USD 4.41 0.15 3.29% |
Roughly 83 percent of Portage Biotech's stockholders are selling. The analysis of the overall investor sentiment regarding Portage Biotech suggests that a large number of traders are terrified. The current market sentiment, together with Portage Biotech's historical and current headlines, can help investors time the market. In addition, many technical investors use Portage Biotech stock news signals to limit their universe of possible portfolio assets.
Portage |
Portage Biotech receives Nasdaq noncompliance notice for minimum shareholders equity.
Read at seekingalpha.com
Portage Biotech Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Portage Biotech can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Portage Biotech Fundamental Analysis
We analyze Portage Biotech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Portage Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Portage Biotech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
EBITDA
EBITDA Comparative Analysis
Portage Biotech is currently under evaluation in ebitda category among its peers. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Portage Biotech Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Portage Biotech stock to make a market-neutral strategy. Peer analysis of Portage Biotech could also be used in its relative valuation, which is a method of valuing Portage Biotech by comparing valuation metrics with similar companies.
Peers
Portage Biotech Related Equities
CUE | Cue Biopharma | 6.62 | ||||
XFOR | X4 Pharmaceuticals | 6.06 | ||||
LCTX | Lineage Cell | 5.00 | ||||
AMLX | Amylyx Pharmaceuticals | 3.99 | ||||
AVTE | Aerovate Therapeutics | 1.55 | ||||
MAIA | MAIA Biotechnology | 1.08 | ||||
EWTX | Edgewise Therapeutics | 0.07 | ||||
FENC | Fennec Pharmaceuticals | 0.76 | ||||
BPMC | Blueprint Medicines | 1.33 | ||||
INZY | Inozyme Pharma | 1.37 | ||||
ARVN | Arvinas | 1.57 | ||||
HRMY | Harmony Biosciences | 1.95 | ||||
ARMP | Armata Pharmaceuticals | 2.44 | ||||
KROS | Keros Therapeutics | 2.65 | ||||
JANX | Janux Therapeutics | 2.92 | ||||
ANEB | Anebulo Pharmaceuticals | 3.14 | ||||
DAWN | Day One | 3.81 | ||||
ABOS | Acumen Pharmaceuticals | 3.85 |
Complementary Tools for Portage Stock analysis
When running Portage Biotech's price analysis, check to measure Portage Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Portage Biotech is operating at the current time. Most of Portage Biotech's value examination focuses on studying past and present price action to predict the probability of Portage Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Portage Biotech's price. Additionally, you may evaluate how the addition of Portage Biotech to your portfolios can decrease your overall portfolio volatility.
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |